- Report
- April 2026
- 143 Pages
India
From €2271EUR$2,499USD£1,952GBP
€3634EUR$3,999USD£3,124GBP
- Report
- March 2026
- 136 Pages
France
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- February 2026
- 149 Pages
Canada
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- July 2024
- 138 Pages
Brazil
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- August 2026
- 70 Pages
Egypt
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 70 Pages
China
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 70 Pages
Mexico
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 70 Pages
Vietnam
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 70 Pages
Mexico
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 70 Pages
Malaysia
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 70 Pages
Thailand
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 120 Pages
Mexico
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2026
- 125 Pages
Canada
From €4316EUR$4,750USD£3,710GBP
- Report
- January 2026
- 70 Pages
Indonesia
From €4316EUR$4,750USD£3,710GBP
- Report
- May 2025
- 70 Pages
Japan
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2024
- 70 Pages
Brazil
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2024
- 70 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- February 2024
- 70 Pages
South Africa
From €4316EUR$4,750USD£3,710GBP
- Report
- February 2024
- 70 Pages
North America
From €4316EUR$4,750USD£3,710GBP
- Report
- February 2024
- 70 Pages
United States
From €4316EUR$4,750USD£3,710GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more